Systemic capillary leak syndrome after ChAdOx1 nCOV-19 (Oxford-AstraZeneca) vaccination

CMAJ. 2021 Aug 30;193(34):E1341-E1344. doi: 10.1503/cmaj.211212. Epub 2021 Aug 6.

Authors

Julie Robichaud¹, Catherine Côté², Fanny Côté²

Affiliations

¹ Departments of Critical Care Medicine and Internal Medicine (Robichaud), Pharmacy (C. Côté) and Internal Medicine (F. Côté), CIUSSS Saguenay-Lac-Saint-Jean, Chicoutimi, Que. julie.robichaud.med@ssss.gouv.qc.ca.
² Departments of Critical Care Medicine and Internal Medicine (Robichaud), Pharmacy (C. Côté) and Internal Medicine (F. Côté), CIUSSS Saguenay-Lac-Saint-Jean, Chicoutimi, Que.

No abstract available

Publication types

Case Reports

MeSH terms

Aged
COVID-19 / prevention & control
COVID-19 Vaccines / adverse effects*
COVID-19 Vaccines / immunology
Capillary Leak Syndrome / chemically induced*
Capillary Leak Syndrome / immunology
ChAdOx1 nCoV-19
Humans
Male
Vaccination / adverse effects

Substances

COVID-19 Vaccines
ChAdOx1 nCoV-19